Where is the live CopyMark page for USPTO serial 76312427?

The live record is at https://getcopymark.com/trademark/76312427. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns INGENIUM DEDUCTIVE PROTEOMICS?

According to the public USPTO record for serial number 76312427, the listed owner(s) include: Ingenium Pharmaceuticals AG.

What is USPTO serial number 76312427?

Serial number 76312427 is the USPTO application identifier for the mark INGENIUM DEDUCTIVE PROTEOMICS. It is used to track examination, publication, and registration of this trademark.

What is the current status of INGENIUM DEDUCTIVE PROTEOMICS?

INGENIUM DEDUCTIVE PROTEOMICS (76312427) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover INGENIUM DEDUCTIVE PROTEOMICS?

The public record lists International Classes: 001, 005, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: INGENIUM DEDUCTIVE PROTEOMICS Serial# 76312427 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INGENIUM DEDUCTIVE PROTEOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Ingenium Pharmaceuticals AG
82152 Martinsried, DE
Other trademarks owned by Ingenium Pharmaceuticals AG

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Talivaldis Cepuritis

TALIVALDIS CEPURITIS OLSON & HIERL, LTD20 N WACKER DR FL 36CHICAGO, IL 60606-2806UNITED STATES

Goods and services

Class	Description	Status	First use
001	CHEMICALS, NAMELY DIAGNOSTIC REAGENTS FOR SCIENTIFIC AND/OR RESEARCH USE	ACTIVE	—
005	PHARMACEUTICAL PREPARATIONS, NAMELY, THERAPEUTICS, NAMELY, DIAGNOSTIC REAGENTS FOR CLINICAL OR MEDICAL LABORATORY USE; CLINICAL MEDICAL REAGENTS FOR USE IN THE TREATMENT OF CANCER, PAIN, NEUROLOGICAL, IMMUNOLOGICAL, CARDIAC AND METABOLIC DISEASE	ACTIVE	—
042	CHEMICAL AND BIOLOGICAL LABORATORIES	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 21, 2002	ABN1	ABANDONMENT - EXPRESS MAILED	—
Nov 4, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Nov 4, 2002	MAIL	PAPER RECEIVED	—
Jul 17, 2002	CNFR	FINAL REFUSAL MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 24, 2002	DOCK	ASSIGNED TO EXAMINER	—
Jun 18, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 6, 2002	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 6, 2002	MAIL	PAPER RECEIVED	—
May 13, 2002	DOCK	ASSIGNED TO EXAMINER	—
Dec 3, 2001	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 19, 2001	DOCK	ASSIGNED TO EXAMINER	—
Nov 15, 2001	DOCK	ASSIGNED TO EXAMINER	—
Oct 22, 2001	UNPR	UNRESPONSIVE/DUPLICATE PAPER RECEIVED	—

INGENIUM DEDUCTIVE PROTEOMICS